What is the initial test to evaluate for pulmonary embolism (PE) in a patient with suspected PE?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Test to Evaluate for Pulmonary Embolism

The first step is to assess pretest probability using a validated clinical prediction rule (Wells score or revised Geneva score), then apply the Pulmonary Embolism Rule-Out Criteria (PERC) for low-risk patients or obtain high-sensitivity D-dimer testing—not imaging—as the initial diagnostic test for low and intermediate probability patients. 1

Step 1: Pretest Probability Assessment

Before ordering any test, you must stratify the patient's risk using one of these validated approaches:

  • Wells score or revised Geneva score are equally accurate and should be used to categorize patients into low (10% PE prevalence), intermediate (30%), or high (~65%) probability groups 1, 2
  • Clinical gestalt by experienced clinicians performs equally well as formal prediction rules, with sensitivity of 97% and specificity of 22%, though structured tools help standardize evaluation for less experienced clinicians 1, 3
  • The Wells score includes: clinical signs of DVT (3 points), PE as likely as alternative diagnosis (3 points), heart rate >100 bpm (1.5 points), immobilization/surgery (1.5 points), previous PE/DVT (1.5 points), hemoptysis (1 point), and malignancy (1 point) 1, 4

Step 2: Apply PERC for Low-Risk Patients

For patients with low pretest probability, apply all 8 PERC criteria before ordering any tests:

  • Age <50 years, pulse <100 bpm, oxygen saturation ≥95%, no hemoptysis, no estrogen use, no prior VTE, no recent surgery/trauma within 4 weeks, and no unilateral leg swelling 1, 3, 5
  • If all 8 PERC criteria are met, stop—no further testing is needed 1, 3
  • PERC has a miss rate of only 0.3% when properly applied and avoids 22% of unnecessary D-dimer tests 3, 5

Critical pitfall: PERC should never be applied to intermediate or high-risk patients—it is only for low pretest probability patients 3, 5

Step 3: High-Sensitivity D-Dimer Testing

D-dimer is the initial diagnostic test for:

  • Low pretest probability patients who do not meet all PERC criteria 1
  • All intermediate pretest probability patients 1

D-dimer interpretation:

  • For patients ≤50 years: use standard cutoff of <500 ng/mL 4
  • For patients >50 years: use age-adjusted cutoff (age × 10 ng/mL), which increases the proportion of patients in whom PE can be excluded from 6.4% to 30% without additional false-negative findings 1, 4
  • Only high-sensitivity D-dimer assays (ELISA or turbidimetric) should be used, with sensitivity of 96% and specificity of 35% 1, 3

If D-dimer is below the appropriate threshold, PE is excluded—no imaging is needed 1, 6

Step 4: Imaging for High Pretest Probability

For high pretest probability patients, proceed directly to CT pulmonary angiography (CTPA) without D-dimer testing:

  • A negative D-dimer cannot safely exclude PE in high-probability patients, so skip D-dimer entirely and go straight to imaging 1, 3
  • CTPA has sensitivity >95% for segmental or larger emboli and is the primary imaging modality for hemodynamically stable patients 3, 7
  • Reserve ventilation-perfusion (V/Q) scans for patients with contraindication to CTPA or when CTPA is unavailable 1, 3

Important Caveats

D-dimer in hospitalized patients: D-dimer specificity is lower in inpatients due to comorbidities, recent surgery, infection, and inflammation—fewer than 10% of hospitalized patients will have a negative D-dimer. However, testing remains appropriate because sensitivity stays high, and a normal level combined with appropriate risk stratification can still prevent unnecessary imaging 1, 3, 4

Never order D-dimer as a screening test: D-dimer should only be ordered after pretest probability assessment, not indiscriminately for all patients with respiratory symptoms 3, 4

Imaging is never the initial test for low or intermediate probability patients—this approach leads to overdiagnosis, unnecessary radiation exposure, and false-positive results 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Age-Adjusted D-Dimer Testing for Pulmonary Embolism Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evaluation of Pulmonary Embolism in Low-Risk Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis of pulmonary embolism: Advances and pitfalls.

Best practice & research. Clinical haematology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.